Cargando…
Evidence of Cooperation between Hippo Pathway and RAS Mutation in Thyroid Carcinomas
SIMPLE SUMMARY: RAS mutations have been reported in a wide range of thyroid cancer histological types, from benign to aggressive phenotypes. The presence of RAS mutations in benign lesions suggests that the mutation alone is unlikely to lead to a malignant transformation per se, and thus, additional...
Autores principales: | Carneiro, Thaise Nayane Ribeiro, Bim, Larissa Valdemarin, Buzatto, Vanessa Candiotti, Galdeno, Vanessa, Asprino, Paula Fontes, Lee, Eunjung Alice, Galante, Pedro Alexandre Favoretto, Cerutti, Janete Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151534/ https://www.ncbi.nlm.nih.gov/pubmed/34065786 http://dx.doi.org/10.3390/cancers13102306 |
Ejemplares similares
-
Molecular Signature Expands the Landscape of Driver Negative Thyroid Cancers
por: Bim, Larissa Valdemarin, et al.
Publicado: (2021) -
Identification of NID1 as a novel candidate susceptibility gene for familial non-medullary thyroid carcinoma using whole-exome sequencing
por: de Mello, Luis Eduardo Barbalho, et al.
Publicado: (2021) -
Advances in Detecting Low Prevalence Somatic TERT Promoter Mutations in Papillary Thyroid Carcinoma
por: da Costa, Vitor Rodrigues, et al.
Publicado: (2021) -
Retroposed copies of RET gene: a somatically acquired event in medullary thyroid carcinoma
por: Bim, Larissa V., et al.
Publicado: (2019) -
New somatic mutations and WNK1-B4GALNT3 gene fusion in papillary thyroid carcinoma
por: Costa, Valerio, et al.
Publicado: (2015)